Eocene Ltd. (EOCN) Stock Ticker
Market factors today
Unlock the full EOCN picture
About Eocene Ltd.
Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
EOCN stock facts
| Ticker symbol | EOCN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $3.8M |
| CEO | Allen J. Baharaff |
| Employees | 6 |
| Headquarters | Ramat Gan, TA, IL |
| IPO date | 2026-09-10 |
| Website | galmedpharma.com |
What you can see for EOCN on Tickr
Live EOCN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the EOCN report.
Rankings
FAQ
What is the ticker symbol for Eocene Ltd.?
The ticker symbol for Eocene Ltd. is EOCN, listed on the NASDAQ.
What is EOCN?
Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The…